Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma

[1]  J. Cerhan,et al.  Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. , 2006, Carcinogenesis.

[2]  R. Piva,et al.  NF-kappaB: a stress-regulated switch for cell survival. , 2006, Antioxidants & redox signaling.

[3]  Y. Hiraku,et al.  Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis , 2006, Biological chemistry.

[4]  A. Iliadou,et al.  Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[5]  H. Adami,et al.  Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. , 2006, Journal of the National Cancer Institute.

[6]  Hugues Sicotte,et al.  SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes , 2005, Nucleic Acids Res..

[7]  M. Forrest,et al.  Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. , 2006, Haematologica.

[8]  J. Cerhan,et al.  Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. , 2005, American journal of epidemiology.

[9]  Robin A Roberts,et al.  A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. , 2005, Blood.

[10]  K. Santos,et al.  Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients. , 2005, Journal of nephrology.

[11]  P. Newburger,et al.  The Effect of IFN-γ and TNF-α on the NADPH Oxidase System of Human Colostrum Macrophages, Blood Monocytes, and THP-1 Cells , 2005 .

[12]  Jinbo Chen,et al.  Genetic Variation and Willingness to Participate in Epidemiologic Research: Data from Three Studies , 2005, Cancer Epidemiology Biomarkers & Prevention.

[13]  G. Zalba,et al.  NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension. , 2005, Antioxidants & redox signaling.

[14]  H. Poulsen.  Oxidative DNA modifications. , 2005, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[15]  G. Halliday,et al.  Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. , 2005, Mutation research.

[16]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[17]  Nathaniel Rothman,et al.  Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. , 2004, Carcinogenesis.

[18]  I. Nagaoka,et al.  Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. , 2004, Atherosclerosis.

[19]  A. Segal,et al.  The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems. , 2004, Biochimica et biophysica acta.

[20]  A. Demaine,et al.  The Association of NAD(P)H Oxidase p22phox With Diabetic Nephropathy Is Still Uncertain , 2004 .

[21]  K. Tokunaga,et al.  The association of NAD(P)H oxidase p22phox with diabetic nephropathy is still uncertain: response to Hodgkinson, Millward, and Demaine. , 2004, Diabetes care.

[22]  N. Rothman,et al.  Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. , 2004, American journal of epidemiology.

[23]  T. Saruta,et al.  Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. , 2004, Diabetes care.

[24]  Theodore R Holford,et al.  Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. , 2004, American journal of epidemiology.

[25]  Nathaniel Rothman,et al.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.

[26]  P. Boyle,et al.  Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women , 2003, British Journal of Cancer.

[27]  H. Krokan,et al.  The interacting pathways for prevention and repair of oxidative DNA damage. , 2003, Mutation research.

[28]  N. Caporaso.  The molecular epidemiology of oxidative damage to DNA and cancer. , 2003, Journal of the National Cancer Institute.

[29]  S. Kuersten,et al.  The power of the 3′ UTR: translational control and development , 2003, Nature Reviews Genetics.

[30]  S. Srivastava,et al.  Gene regulation of aldose-, aldehyde- and a renal specific oxido reductase (RSOR) in the pathobiology of diabetes mellitus. , 2003, Current medicinal chemistry.

[31]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[32]  Ulrich Siebenlist,et al.  Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells , 2001, The Journal of experimental medicine.

[33]  P. Wiernik,et al.  Systemic lupus erythematosus and B-cell hematologic neoplasm , 2001, Lupus.

[34]  J. Hescheler,et al.  Reactive Oxygen Species as Intracellular Messengers During Cell Growth and Differentiation , 2001, Cellular Physiology and Biochemistry.

[35]  J. Yokota,et al.  The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. , 2001, Antioxidants & redox signaling.

[36]  J. Jez,et al.  The aldo-keto reductase (AKR) superfamily: an update. , 2001, Chemico-biological interactions.

[37]  K. Channon,et al.  Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis , 2000, Circulation.

[38]  S. L. Hazen,et al.  p-Hydroxyphenylacetaldehyde, an Aldehyde Generated by Myeloperoxidase, Modifies Phospholipid Amino Groups of Low Density Lipoprotein in Human Atherosclerotic Intima* , 2000, The Journal of Biological Chemistry.

[39]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[40]  G. FitzGerald,et al.  Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo * , 1999, The Journal of Biological Chemistry.

[41]  K. Kanazawa,et al.  Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. , 1998, Circulation.

[42]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[43]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[44]  J. Morrow,et al.  Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver. , 1994, Science.

[45]  M. Bewick,et al.  Superoxide dismutase, glutathione peroxidase and catalase in the red cells of patients with malignant lymphoma , 1987, British journal of haematology.